MicroRNA‑125a‑mediated regulation of the mevalonate signaling pathway contributes to high glucose‑induced proliferation and migration of vascular smooth muscle cells
Open Access
- 16 April 2020
- journal article
- research article
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 22 (1) , 165-174
Abstract
Hyperglycemia contributes to the excessive proliferation and migration of vascular smooth muscle cells (VSMC), which are closely associated with atherosclerosis. MicroRNAs (miRNAs/miRs) constitute a novel class of gene regulators, which have important roles in various pathological conditions. The aim of the present study was to identify miRNAs involved in the high glucose (HG)‑induced VSMC phenotype switch, and to investigate the underlying mechanism. miRNA sequencing and reverse transcription‑quantitative PCR results indicated that inhibition of miR‑125a expression increased the migration and proliferation of VSMCs following HG exposure, whereas the overexpression of miR‑125a abrogated this effect. Furthermore, dual‑luciferase reporter assay results identified that 3‑hydroxy‑3-methyglutaryl‑coA reductase (HMGCR), one of the key enzymes in the mevalonate signaling pathway, is a target of miR‑125a. Moreover, HMGCR knockdown, similarly to miR‑125a overexpression, suppressed HG‑induced VSMC proliferation and migration. These results were consistent with those from the miRNA target prediction programs. Using a rat model of streptozotocin‑induced diabetes mellitus, it was demonstrated that miR‑125a expression was gradually downregulated, and that the expressions of key enzymes in the mevalonate signaling pathway in the aortic media were dysregulated after several weeks. In addition, it was found that HG‑induced excessive activation of the mevalonate signaling pathway in VSMCs was suppressed following transfection with a miR‑125a mimic. Therefore, the present results suggest that decreased miR‑125a expression contributed to HG‑induced VSMC proliferation and migration via the upregulation of HMGCR expression. Thus, miR‑125a‑mediated regulation of the mevalonate signaling pathway may be associated with atherosclerosis.Keywords
This publication has 37 references indexed in Scilit:
- Diverse functions of miR-125 family in different cell contextsJournal of Hematology & Oncology, 2013
- MicroRNA‐26a is a novel regulator of vascular smooth muscle cell functionJournal of Cellular Physiology, 2010
- miR-145 and miR-143 regulate smooth muscle cell fate and plasticityNature, 2009
- Diabetes and atherosclerosis: is there a role for hyperglycemia?Journal of Lipid Research, 2009
- A Necessary Role of miR-221 and miR-222 in Vascular Smooth Muscle Cell Proliferation and Neointimal HyperplasiaCirculation Research, 2009
- Origins and Mechanisms of miRNAs and siRNAsCell, 2009
- Tissue microarrays characterise the clinical significance of a VEGF-A protein expression signature in gastrointestinal stromal tumoursBritish Journal of Cancer, 2007
- MicroRNAs: small RNAs with a big role in gene regulationNature Reviews Genetics, 2004
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Regulation of the mevalonate pathwayNature, 1990